title: Prostate cancer: cabozantinib reduces pain and narcotic use in men with CRPC.
authors.forename: Melanie
authors.initials: M
authors.lastname: Clyne
mesh_terms: D000813:Anilides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D064129:Prostatic Neoplasms, Castration-Resistant / Q000150:complications*; D011725:Pyridines / Q000627:therapeutic use*; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D000813:Anilides; D011725:Pyridines; C558660:cabozantinib; D020794:Receptor Protein-Tyrosine Kinases